This In-Depth Focus explores how BPCs, RMMs and AI-enabled analytics are being evaluated as a tool to enhance aseptic manufacturing, bioburden testing and monitoring.
A recent market report projecting the combined NIR and Raman spectroscopy sector will reach $2.35 billion in 2026 underscores the rapid adoption of vibrational spectroscopy across biopharmaceutical manufacturing, with AI-enhanced Raman tools increasingly being deployed for real-time quality control.
During this virtual panel, industry experts will discuss practical examples and considerations for transforming manufacturing processes.
EPR Issue 1 includes articles on manufacturing, drug delivery, environmental monitoring, analytical techniques and more.
General Manager Brian Morrissey discusses his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
General Manager Brian Morrissey discusses his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
Sartorius BIA Separations illustrates a promising alternative approach for efficient lentiviral vector purification that delivers a scalable, GMP-ready biomanufacturing solution.
EPR’s 2026 pharma manufacturing trends report covers the key developments in supply chain, quality, drug development, new modalities and beyond.
Essential for any medicine that must be sterile and safe for injection, ROIS’ Miguel Ángel Ortega Sánchez presents the case for outsourcing WFI production to a trusted partner.
Experts from WuXi Biologics explain how next-generation cell line development with targeted integration advances the field by enabling the production of clonal cell lines with predictable transgene copies at specific, predefined sites in the host genome.
The three-day MSS2026 event takes place in September in Slovenia, with online attendance options also available.
People, not platforms, will define the next era of innovation, explain Chiesi’s Executive VP of R&D Diego Ardigò and Nick Petschek, EMEA Managing Director at Kotter.
As vaccines are buffeted by political pressures, the CDMO discussed its growth approach and some of its key collaborations.
Named CEO of the Year at CPHI Frankfurt, the CDMO’s head talks about the type of company he and his team are building.
The critical role of identification and documentation in contamination control.
Here, Hexagon outlines a four-step plan to address silos and scale-up challenges, drawing on the experience of leading pharma firms like Pfizer.
CDMOs weigh up how to meet manufacturing demands across oral solid doses, monoclonal antibodies, ADCs and beyond.
MBV AG addresses challenges in air monitoring and aseptic handling with MAS-100 Sirius®: a next‑generation active microbial air sampler created in close collaboration with pharmaceutical manufacturers and cleanroom experts.
Nippon Muki demonstrates the performance advantages of its innovative HEPA filter for the sterilisation of injectable containers in pharmaceutical manufacturing.
EPR Issue 4 includes articles on manufacturing, AI/ML, vaccine development, biologics and more.